Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

June 2011 - FRMC

Feature
Long-Term Bisphosphonate Use Associated with Greater Risk of Atypical Fractures
06/21/2011
A large cohort study of women found that use of oral bisphosphonates for >5 years increased the risk of subtrochanteric or femoral shaft fractures, although the absolute risk of these fractures is low [JAMA. 2011;305(8):783-789]. Whereas...
A large cohort study of women found that use of oral bisphosphonates for >5 years increased the risk of subtrochanteric or femoral shaft fractures, although the absolute risk of these fractures is low [JAMA. 2011;305(8):783-789]. Whereas...
A large cohort study of women...
06/21/2011
First Report Managed Care
Feature
Smoking in Midlife and the Long-Term Risk of Dementia
06/21/2011
It is well known that smoking increases the risk of most diseases and death, but some studies suggest that smoking is also associated with a lower risk of certain neurodegenerative diseases, including Parkinson’s disease. Other studies have...
It is well known that smoking increases the risk of most diseases and death, but some studies suggest that smoking is also associated with a lower risk of certain neurodegenerative diseases, including Parkinson’s disease. Other studies have...
It is well known that smoking...
06/21/2011
First Report Managed Care
Feature
Nitroglycerin Ointment and Changes in Bone Mineral Density in Postmenopausal Women
06/21/2011
As populations worldwide age, the number of osteoporotic fractures is increasing.
As populations worldwide age, the number of osteoporotic fractures is increasing.
As populations worldwide age,...
06/21/2011
First Report Managed Care
Feature
Motivational Intervention with Parental Participation in Adolescent Alcohol Use
06/21/2011
There have been various efforts to improve awareness and to reduce substance abuse among adolescents. Studies have shown that for 18- to 19-year-old adolescents, an individual motivational interview (IMI) effectively reduces alcohol-related...
There have been various efforts to improve awareness and to reduce substance abuse among adolescents. Studies have shown that for 18- to 19-year-old adolescents, an individual motivational interview (IMI) effectively reduces alcohol-related...
There have been various efforts...
06/21/2011
First Report Managed Care
Feature
Behavioral Health Screening Rate after Court-Mandated Program
06/21/2011
The Task Force on Mental Health of the American Academy of Pediatrics has recently endorsed mental health screening in primary care as a way to help the effort to prevent mental health disorders for children and adolescents. Studies have...
The Task Force on Mental Health of the American Academy of Pediatrics has recently endorsed mental health screening in primary care as a way to help the effort to prevent mental health disorders for children and adolescents. Studies have...
The Task Force on Mental Health...
06/21/2011
First Report Managed Care
Feature
Prescription Drug Spending in 2008
06/21/2011
The Agency for Healthcare Research and Quality (AHRQ) recently issued Statistical Brief #313 identifying the top 5 therapeutic classes of outpatient prescription drugs in 2008 for adults age ≥18 in terms of expenditures. AHRQ ranked metabolic...
The Agency for Healthcare Research and Quality (AHRQ) recently issued Statistical Brief #313 identifying the top 5 therapeutic classes of outpatient prescription drugs in 2008 for adults age ≥18 in terms of expenditures. AHRQ ranked metabolic...
The Agency for Healthcare...
06/21/2011
First Report Managed Care
Feature
Intermediate versus High Dose of Cytarabine for Acute Myeloid Leukemia
06/21/2011
For >30 years, acute myeloid leukemia (AML) has been treated with cytarabine. Initially, the drug was used in remission-induction therapy at a dose of 100 to 200 mg per square meter of body surface area. High-dose therapy was evaluated...
For >30 years, acute myeloid leukemia (AML) has been treated with cytarabine. Initially, the drug was used in remission-induction therapy at a dose of 100 to 200 mg per square meter of body surface area. High-dose therapy was evaluated...
For >30 years, acute myeloid...
06/21/2011
First Report Managed Care
Feature
Emphysema and Lung Volume in Smokers with Interstitial Lung Abnormalities
06/17/2011
Chronic obstructive pulmonary disease (COPD) may be manifested by emphysematous destruction of the lung parenchyma and elevated measures of total lung capacity, conditions often associated with exposure to tobacco smoke. is increased...
Chronic obstructive pulmonary disease (COPD) may be manifested by emphysematous destruction of the lung parenchyma and elevated measures of total lung capacity, conditions often associated with exposure to tobacco smoke. is increased...
Chronic obstructive pulmonary...
06/17/2011
First Report Managed Care
Feature
Treatment of Non–Small-Cell Lung Cancer with Erlotinib and Gefitinib
06/17/2011
Non–small-cell lung cancer (NSCLC) is a common and often a challenging form of cancer to treat, but erlotinib and gefitinib could be effective treatment options—especially for patients who have tumors with gene mutations that activate the...
Non–small-cell lung cancer (NSCLC) is a common and often a challenging form of cancer to treat, but erlotinib and gefitinib could be effective treatment options—especially for patients who have tumors with gene mutations that activate the...
Non–small-cell lung cancer...
06/17/2011
First Report Managed Care
Feature
Latest Tracking Poll Shows Little Support for Changing Medicaid
06/17/2011
The latest tracking poll (May 2011) conducted by the Henry J. Kaiser Family Foundation found that overall there is little public support for cutting Medicaid spending or changing the program to a block grant to reduce the federal deficit....
The latest tracking poll (May 2011) conducted by the Henry J. Kaiser Family Foundation found that overall there is little public support for cutting Medicaid spending or changing the program to a block grant to reduce the federal deficit....
The latest tracking poll (May...
06/17/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Conference Insider
Patient-Reported Outcomes Similarly Impacted By Migraine Treatments
05/17/2019
Researchers recently found that patient-reported outcomes (PROs) were no different among patients treated with calcitonin gene-related peptide (CGRP) antagonists or onabotulinumtoxinA (ONA) for the indication of chronic migraine prophylaxis. 
Researchers recently found that patient-reported outcomes (PROs) were no different among patients treated with calcitonin gene-related peptide (CGRP) antagonists or onabotulinumtoxinA (ONA) for the indication of chronic migraine prophylaxis. 
Researchers recently found that...
05/17/2019
First Report Managed Care
News
Cancer`s growing burden: the high cost of care
03/02/2012
03/02/2012
First Report Managed Care
Mergers Pave Way for Good Opportunity to Enter Medicare Advantage Market
11/06/2015
While the largest insurance companies await their fate at the hands of federal regulators, other plans and investors should pay close attention to the opportunity to acquire divested plans from the two deals.
While the largest insurance companies await their fate at the hands of federal regulators, other plans and investors should pay close attention to the opportunity to acquire divested plans from the two deals.
While the largest insurance...
11/06/2015
First Report Managed Care
News
Trial to Test CAR T-Cell Therapy for Refractory Progressive MS
03/18/2024
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
News
Cost-Effective Treatment Option for Tremor-Dominant Parkinson Disease
10/13/2020
Magnetic resonance-guided focused ultrasound thalamotomy is more cost-effective than continued medical therapy for patients with tremor-dominant Parkinson disease.
Magnetic resonance-guided focused ultrasound thalamotomy is more cost-effective than continued medical therapy for patients with tremor-dominant Parkinson disease.
Magnetic resonance-guided...
10/13/2020
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

June 2011 Volume 8 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement